For the Media
Dr. Davidson is the Director and a Member of the Clinical Research Division and Senior Vice President at Fred Hutchinson Cancer Research Center. She is also the President and Executive Director of the Fred Hutch’s patient-care arm, Seattle Cancer Care Alliance (SCCA), and a Professor and Head of the Division of Medical Oncology of the University of Washington (UW) School of Medicine.
Leadership bio for Nancy E. Davidson
As Clinical Research Division Director, Davidson serves as a bridge builder across the cancer treatment, clinical, translational, basic sciences and public health research programs of consortium members Fred Hutch, UW School of Medicine, UW School of Public Health, Seattle Children’s and SCCA.
Overview of Nancy E. Davidson's Research
Dr. Davidson is a world-recognized leader in the fields of breast cancer biology and treatment, having conducted laboratory research on the role of hormones in breast cancer growth.
Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.